Page 7 - Contract Development News Today

/PRNewswire/ -- Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, today announced that they have entered into a collaboration and...

Armed with resilience, commitment and a passion for plant bioactives, Israel based-biotech company Bioharvest Sciences continues to meet consumer demand despite the ongoing conflict in the region.

Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The

Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.

The company has a portfolio of over 75 products in CDMO services across the US, Canada, Europe, Australia, and LATAM markets.

 Press Release     Paris – April 30, 2024 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 22, 2024 at 10:00 a.m. at the Centre de...

FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million

-Visit OBiO Tech booth #1644 at  American Society of Gene & Cell Therapy in Maryland, USA SHANGHAI, April 28, 2024 /PRNewswire/ — OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene therapy, will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th. 9 posters will […]

-Visit OBiO Tech booth #1644 at American Society of Gene & Cell Therapy in Maryland, USA SHANGHAI, April 28, 2024 /PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract

/PRNewswire/ -- OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene...